WallStreetZenWallStreetZen

NASDAQ: LITS
Lite Strategy Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their LITS stock forecasts and price targets.

Forecast return on equity

Is LITS forecast to generate an efficient return?

Company
-116.24%
Industry
-18.19%
Market
132.43%
LITS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is LITS forecast to generate an efficient return on assets?

Company
-113.33%
Industry
-15.79%
LITS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

LITS earnings per share forecast

What is LITS's earnings per share in the next 1 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$1.59

LITS revenue forecast

What is LITS's revenue in the next 1 years based on estimates from 4 analysts?

Avg 1 year Forecast
$25.5M

LITS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
LITS$1.27N/AN/A
MGX$1.00$6.00+500.00%Strong Buy
FLNA$0.82$5.00+512.00%Strong Buy
VERU$2.46$25.67+943.37%Strong Buy
ATNM$1.10N/AN/A
View Top Biotech Stocks

Lite Strategy Stock Forecast FAQ

What is LITS's earnings growth forecast for 2027-2027?

(NASDAQ: LITS) Lite Strategy's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 22.91%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,187.83%.

Lite Strategy's earnings in 2026 is -$71,150,000.

In 2027, LITS is forecast to generate -$48,384,045 in earnings, with the lowest earnings forecast at -$46,486,631 and the highest earnings forecast at -$49,807,105.

If you're new to stock investing, here's how to buy Lite Strategy stock.

What is LITS's revenue growth forecast for 2027-2027?

(NASDAQ: LITS) Lite Strategy's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 11.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 24.59%.

Lite Strategy's revenue in 2026 is $0.

In 2027, LITS is forecast to generate $775,385,334 in revenue, with the lowest revenue forecast at $744,978,066 and the highest revenue forecast at $798,190,785.

What is LITS's forecast return on assets (ROA) for 2027-2027?

(NASDAQ: LITS) forecast ROA is -113.33%, which is lower than the forecast US Biotechnology industry average of -15.79%.

What is LITS's Earnings Per Share (EPS) forecast for 2027-2027?

(NASDAQ: LITS) Lite Strategy's current Earnings Per Share (EPS) is -$2.06. In 2027, LITS's EPS is forecast to hit -$1.59 (min: -$1.53, max: -$1.64).

What is LITS's forecast return on equity (ROE) for 2027-2027?

(NASDAQ: LITS) forecast ROE is -116.24%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.